Literature DB >> 11866441

Exip, a new alternative splicing variant of p38 alpha, can induce an earlier onset of apoptosis in HeLa cells.

Tatsuhiko Sudo1, Yuki Yagasaki, Hiroshi Hama, Naoko Watanabe, Hiroyuki Osada.   

Abstract

One of the major families of the mitogen-activated kinases (MAPK), p38, has been shown to transduce extracellular stress stimuli into cellular responses. Among them, p38 alpha is the best characterized isoform and many biological phenomena, especially in the inflammatory responses, were attributed to the specific inhibitor-sensitive isoforms, namely p38 alpha and p38 beta. However, the roles played by each member are still unclear. Here, we report the identification of a new splice variant of p38 alpha, Exip (for exon skip), by RT-PCR using mRNA derived from a renal tumor cell line, OS-RC-2. Exip is predicted to encode a 307-amino-acid protein and the absence of exons 10, 11, and 11' results in the shift of the reading frame at the exon 9-12 junction to produce a unique 53-amino-acid C-terminus. The expression of mRNA was barely observed in cultured cells tested, but substantial amounts of mRNA were detected in mouse tissues. Unlike p38 alpha, Exip lost a common docking domain well conserved in major MAPK families for their specific interactions with upstream kinases or downstream substrates. Even though Exip is not phosphorylated at conserved TGY motif by p38-activating treatments, such as an osmotic shock or coexpression with a constitutive active form of MKK6 in HeLa cells, Exip can induce an earlier onset of apoptosis in HeLa cells. These results indicate that Exip has unique properties as a member of p38 alpha and may play role(s) in the signal transduction pathway(s) different from those of p38 alpha.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11866441     DOI: 10.1006/bbrc.2002.6529

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Astrocytes express Mxi2, a splice isoform of p38MAPK.

Authors:  Guillermo Bodega; Sergio Ciordia; Isabel Suárez; Luis Andrés López-Fernández; Enrique Vacas; Gonzalo Sánchez-Tejeda; María Amparo Albert; Silvia Juárez; Juan Pablo Albar; Benjamín Fernández
Journal:  J Mol Histol       Date:  2009-12-31       Impact factor: 2.611

2.  The role of p38 in mitochondrial respiration in male and female mice.

Authors:  Xiaohua Ju; Yi Wen; Daniel Metzger; Marianna Jung
Journal:  Neurosci Lett       Date:  2013-04-17       Impact factor: 3.046

3.  Specific phosphorylation and activation of ERK1c by MEK1b: a unique route in the ERK cascade.

Authors:  Yoav D Shaul; Gilad Gibor; Alexander Plotnikov; Rony Seger
Journal:  Genes Dev       Date:  2009-08-01       Impact factor: 11.361

4.  Comparative chemical array screening for p38γ/δ MAPK inhibitors using a single gatekeeper residue difference between p38α/β and p38γ/δ.

Authors:  Yasumitsu Kondoh; Kaori Honda; Sayoko Hiranuma; Teruo Hayashi; Takeshi Shimizu; Nobumoto Watanabe; Hiroyuki Osada
Journal:  Sci Rep       Date:  2016-07-19       Impact factor: 4.379

Review 5.  Diversity and versatility of p38 kinase signalling in health and disease.

Authors:  Begoña Canovas; Angel R Nebreda
Journal:  Nat Rev Mol Cell Biol       Date:  2021-01-27       Impact factor: 113.915

6.  Alternative splicing and protein structure evolution.

Authors:  Fabian Birzele; Gergely Csaba; Ralf Zimmer
Journal:  Nucleic Acids Res       Date:  2007-11-30       Impact factor: 16.971

Review 7.  Alternative Splicing of MAPKs in the Regulation of Signaling Specificity.

Authors:  Galia Maik-Rachline; Inbal Wortzel; Rony Seger
Journal:  Cells       Date:  2021-12-08       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.